Literature DB >> 15193035

Cell death mechanisms following traumatic brain injury.

Ramesh Raghupathi1.   

Abstract

Neuronal and glial cell death and traumatic axonal injury contribute to the overall pathology of traumatic brain injury (TBI) in both humans and animals. In both head-injured humans and following experimental brain injury, dying neural cells exhibit either an apoptotic or a necrotic morphology. Apoptotic and necrotic neurons have been identified within contusions in the acute post-traumatic period, and in regions remote from the site of impact in the days and weeks after trauma, while degenerating oligodendrocytes and astrocytes have been observed within injured white matter tracts. We review and compare the regional and temporal patterns of apoptotic and necrotic cell death following TBI and the possible mechanisms underlying trauma-induced cell death. While excitatory amino acids, increases in intracellular calcium and free radicals can all cause cells to undergo apoptosis, in vitro studies have determined that neural cells can undergo apoptosis via many other pathways. It is generally accepted that a shift in the balance between pro- and anti-apoptotic protein factors towards the expression of proteins that promote death may be one mechanism underlying apoptotic cell death. The effect of TBI on cellular expression of survival promoting-proteins such as Bcl-2, Bcl-xL, and extracellular signal-regulated kinases, and death-inducing proteins such as Bax, c-Jun N-terminal kinase, tumor-suppressor gene, p53, and the calpain and caspase families of proteases are reviewed. In light of pharmacologic strategies that have been devised to reduce the extent of apoptotic cell death in animal models of TBI, our review also considers whether apoptosis may serve a protective role in the injured brain. Together, these observations suggest that cell death mechanisms may be representative of a continuum between apoptotic and necrotic pathways.

Entities:  

Mesh:

Year:  2004        PMID: 15193035     DOI: 10.1111/j.1750-3639.2004.tb00056.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  189 in total

1.  Traumatic Brain Injury Alters the Metabolism and Facilitates Alzheimer's Disease in a Murine Model.

Authors:  Dandan Lou; Yao Du; Daochao Huang; Fang Cai; Yun Zhang; Tinyu Li; Weihui Zhou; Hongchang Gao; Weihong Song
Journal:  Mol Neurobiol       Date:  2017-08-03       Impact factor: 5.590

2.  In vitro stretch injury induces time- and severity-dependent alterations of STEP phosphorylation and proteolysis in neurons.

Authors:  Mahlet N Mesfin; Catherine R von Reyn; Rosalind E Mott; Mary E Putt; David F Meaney
Journal:  J Neurotrauma       Date:  2012-06-25       Impact factor: 5.269

3.  Therapeutic effect of SN50, an inhibitor of nuclear factor-κB, in treatment of TBI in mice.

Authors:  Yu-Xia Sun; Ding-Kun Dai; Ran Liu; Tao Wang; Cheng-Liang Luo; Hai-Jun Bao; Rui Yang; Xue-Ying Feng; Zheng-Hong Qin; Xi-Ping Chen; Lu-Yang Tao
Journal:  Neurol Sci       Date:  2012-03-23       Impact factor: 3.307

Review 4.  A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury.

Authors:  Kevin W McConeghy; Jimmi Hatton; Lindsey Hughes; Aaron M Cook
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

Review 5.  Preconditioning for traumatic brain injury.

Authors:  Shoji Yokobori; Anna T Mazzeo; Khadil Hosein; Shyam Gajavelli; W Dalton Dietrich; M Ross Bullock
Journal:  Transl Stroke Res       Date:  2012-11-15       Impact factor: 6.829

6.  CCL20 Is Associated with Neurodegeneration Following Experimental Traumatic Brain Injury and Promotes Cellular Toxicity In Vitro.

Authors:  Christopher C Leonardo; James Musso; Mahasweta Das; Derrick D Rowe; Lisa A Collier; Shyam Mohapatra; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2012-08-09       Impact factor: 6.829

7.  Acute plasmalemma permeability and protracted clearance of injured cells after controlled cortical impact in mice.

Authors:  Michael J Whalen; Turgay Dalkara; Zerong You; Jianhua Qiu; Daniela Bermpohl; Niyati Mehta; Bernhard Suter; Pradeep G Bhide; Eng H Lo; Maria Ericsson; Michael A Moskowitz
Journal:  J Cereb Blood Flow Metab       Date:  2007-08-22       Impact factor: 6.200

Review 8.  Animal models of traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Nat Rev Neurosci       Date:  2013-02       Impact factor: 34.870

9.  Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury.

Authors:  Nigel H Greig; David Tweedie; Lital Rachmany; Yazhou Li; Vardit Rubovitch; Shaul Schreiber; Yung-Hsiao Chiang; Barry J Hoffer; Jonathan Miller; Debomoy K Lahiri; Kumar Sambamurti; Robert E Becker; Chaim G Pick
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

Review 10.  Chronic Histopathological and Behavioral Outcomes of Experimental Traumatic Brain Injury in Adult Male Animals.

Authors:  Nicole D Osier; Shaun W Carlson; Anthony DeSana; C Edward Dixon
Journal:  J Neurotrauma       Date:  2015-04-15       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.